Revenue
No reported data
Milestone Pharmaceuticals Inc. (MIST)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Research & development | $18.1M | $14.4M | $31.1M | $39.8M | $38.7M | $34.5M | $42.0M | $16.8M |
| Operating income | −$62.1M | −$42.1M | −$61.1M | −$59.6M | −$43.1M | −$50.7M | −$57.9M | −$23.8M |
| EBITDAderived | −$62.0M | −$42.0M | −$61.0M | −$59.6M | −$43.0M | −$50.6M | −$57.8M | −$23.8M |
| Net income | −$63.1M | −$41.5M | −$59.7M | −$58.4M | −$42.9M | −$50.0M | −$55.2M | −$23.2M |
| Basic EPSper diluted share | -$0.75 | -$0.67 | -$1.39 | -$1.38 | -$1.02 | -$1.70 | -$3.50 | $72.63 |
| Diluted EPSper diluted share | -$0.75 | -$0.67 | -$1.39 | -$1.38 | -$1.02 | -$1.70 | -$3.50 | $72.63 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 16, 2026Form 4 · 10b5-1 | Oliveto JosephPresident and CEO | SellCommon Shares | 36.5K | $2.26 | $82.5K | 446.2K |
| Jan 26, 2026Form 4 | Nelson Jeffrey EdwardChief Operating Officer | SellCommon Shares | 12.2K | $1.93 | $23.6K | 49.8K |
| Jan 26, 2026Form 4 | Bharucha DavidChief Medical Officer | SellCommon Shares | 12.2K | $1.93 | $23.6K | 113.2K |
| Jan 26, 2026Form 4 | Hasija AmitCFO & EVP of Corp. Development | SellCommon Shares | 12.2K | $1.93 | $23.6K | 99.8K |
| Jan 26, 2026Form 4 | Muller LorenzChief Commercial Officer | SellCommon Shares | 11.2K | $1.93 | $21.6K | 205.4K |